Ardevora Asset Management Llp Lowered Bristol Myers Squibb Co (BMY) Holding By $422,100; Nicholas Financial Has 0.45 Sentiment

February 22, 2018 - By wolcottdaily

Nicholas Financial, Inc. operates as a specialized consumer finance firm in the United States. The company has market cap of $70.57 million. The firm engages in acquiring and servicing automobile finance installment contracts for the purchase of new and used automobiles and light trucks. It currently has negative earnings. It also originates direct consumer loans and sells consumer-finance related products.

Ardevora Asset Management Llp decreased Bristol Myers Squibb Co (BMY) stake by 1.43% reported in 2017Q3 SEC filing. Ardevora Asset Management Llp sold 6,700 shares as Bristol Myers Squibb Co (BMY)’s stock declined 1.04%. The Ardevora Asset Management Llp holds 462,400 shares with $29.47M value, down from 469,100 last quarter. Bristol Myers Squibb Co now has $108.62B valuation. The stock decreased 1.22% or $0.82 during the last trading session, reaching $66.53. About 7.05 million shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since February 22, 2017 and is downtrending. It has underperformed by 39.89% the S&P500.




The stock decreased 1.97% or $0.18 during the last trading session, reaching $8.95. About 27,806 shares traded or 138.49% up from the average. Nicholas Financial, Inc. (NICK) has declined 21.19% since February 22, 2017 and is downtrending. It has underperformed by 37.89% the S&P500.

Highlander Capital Management Llc holds 0.12% of its portfolio in Nicholas Financial, Inc. for 18,430 shares. Tcw Group Inc owns 600,704 shares or 0.04% of their US portfolio. Moreover, Rbf Capital Llc has 0.03% invested in the company for 30,000 shares. The Texas-based Bridgeway Capital Management Inc has invested 0.01% in the stock. Jbf Capital Inc., a Colorado-based fund reported 11,946 shares.

Since January 1, 0001, it had 1 insider purchase, and 0 selling transactions for $24,036 activity.

Ardevora Asset Management Llp increased O Reilly Automotive Inc New (NASDAQ:ORLY) stake by 15,600 shares to 127,900 valued at $27.55 million in 2017Q3. It also upped Technipfmc Plc stake by 159,800 shares and now owns 1.29M shares. Lennox Intl Inc (NYSE:LII) was raised too.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 3 Sell and 9 Hold. Therefore 37% are positive. Bristol-Myers Squibb Company had 73 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Wednesday, April 26 by Robert W. Baird. The rating was upgraded by Jefferies to “Buy” on Monday, December 19. The firm has “Buy” rating by Berenberg given on Friday, January 22. The firm earned “Hold” rating on Tuesday, June 14 by Jefferies. On Thursday, November 16 the stock rating was maintained by Jefferies with “Hold”. As per Thursday, February 15, the company rating was upgraded by Morgan Stanley. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Hold” rating by Cowen & Co on Monday, August 14. Berenberg downgraded Bristol-Myers Squibb Company (NYSE:BMY) on Thursday, August 11 to “Hold” rating. The stock of Bristol-Myers Squibb Company (NYSE:BMY) has “Market Perform” rating given on Monday, January 25 by BMO Capital Markets. As per Tuesday, September 20, the company rating was maintained by Citigroup.

Since September 6, 2017, it had 1 buying transaction, and 2 insider sales for $646,385 activity. $560,400 worth of Bristol-Myers Squibb Company (NYSE:BMY) shares were sold by Caldarella Joseph C. On Tuesday, December 12 Lynch Thomas J. Jr. sold $335,172 worth of Bristol-Myers Squibb Company (NYSE:BMY) or 5,300 shares. On Friday, December 15 the insider Samuels Theodore R. II bought $249,187.

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on April, 26. They expect $0.87 earnings per share, up 3.57% or $0.03 from last year’s $0.84 per share. BMY’s profit will be $1.42B for 19.12 P/E if the $0.87 EPS becomes a reality. After $0.68 actual earnings per share reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts 27.94% EPS growth.

Investors sentiment increased to 1.03 in 2017 Q3. Its up 0.08, from 0.95 in 2017Q2. It improved, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. 1.11 billion shares or 0.68% more from 1.10 billion shares in 2017Q2 were reported. Hm Payson & stated it has 0.24% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Mutual Of Omaha Fincl Bank Wealth Management reported 13,340 shares. Sii Wi, Wisconsin-based fund reported 18,762 shares. Wheatland has 28,400 shares. Intersect Ltd holds 11,539 shares or 0.42% of its portfolio. Oppenheimer Inc reported 345,538 shares. Rand Wealth Limited Liability Co holds 0.15% or 20,477 shares. Daiwa Secs Grp reported 193,547 shares or 0.08% of all its holdings. Alexandria Cap Limited Liability Corporation holds 0.01% or 801 shares in its portfolio. Moreover, State Board Of Administration Of Florida Retirement System has 0.42% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 2.40 million shares. Whitnell And Communications reported 0.65% stake. Aull And Monroe Investment Management Corp invested 0.67% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). Moreover, Cambridge Inv Research Advsr has 0.16% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 188,137 shares. Sigma Counselors reported 52,314 shares. Art Advisors Ltd Liability Corporation invested 0.62% in Bristol-Myers Squibb Company (NYSE:BMY).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.